Angiotech Pharmaceuticals to participate in Merrill Lynch conference
03 Februar 2006 - 6:32PM
PR Newswire (US)
VANCOUVER, Feb. 3 /PRNewswire-FirstCall/ -- Angiotech
Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), is
scheduled to participate in the Merrill Lynch Global
Pharmaceutical, Biotechnology & Medical Device Conference.
Thomas Bailey, Chief Financial Officer of Angiotech, will be making
a 40-minute presentation at the conference on Wednesday, February
8th, 2006 at 1:40 pm EST (10:40 am PST). This audio-only webcast
presentation will be available through Angiotech's website at
http://www.angiotech.com/. Vancouver-based Angiotech
Pharmaceuticals, Inc. is a specialty pharmaceutical company
pioneering the combination of pharmaceutical compounds with medical
devices and biomaterials to both create novel solutions for poorly
addressed disease states and dramatically improve surgical
outcomes. To find out more about Angiotech Pharmaceuticals, Inc.
(NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), please visit our website at
http://www.angiotech.com/ FOR ADDITIONAL INFORMATION:
--------------------------- Analysts and Investors: Todd Young,
Vice President Investor Relations and Communications Angiotech
Pharmaceuticals, Inc. (604) 221-7676 ext 6933 Media: Colleen
Beauregard Waggener Edstrom Bioscience (503) 443-7863, Email:
DATASOURCE: Angiotech Pharmaceuticals, Inc. CONTACT: Analysts and
Investors: Todd Young, Vice President Investor Relations and
Communications, Angiotech Pharmaceuticals, Inc., (604) 221-7676 ext
6933; Media: Colleen Beauregard, Waggener Edstrom Bioscience, (503)
443-7863, Email:
Copyright
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Angiotech Pharmaceuticals - Common Shares (MM) News-Artikel